Peptides, which the body naturally produces, are chains of amino acids (the building blocks of proteins)
What they do is reduce inflammation, improve DNA repair, and decrease oxidative stress, all key factors in mitigating the cumulative damage caused by sun exposure

Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet

NSL literature pointer PMID 15034235 L-Carnitine laboratory index [PMID: 15034235] National Science Labs indexing note for PMID 15034235: review the PubMed methods, models, and limitations before citing
Retatrutide may help preserve lean mass during weight loss, but some muscle loss can still occur